Part 1: Executive Summary: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care

Appendix 1. Writing Group Disclosures

Appendix 1. Writing Group Disclosures
Writing Group Member Employment Research Grant Other Research Support Speakers' Bureau/
Honoraria
Expert Witness Ownership Interest Consultant/
Advisory Board
Other

Marina Del Rios

The University of Chicago Medicine

National Institutes of Health†

None

None

None

None

None

None

Jeanette K. Previdi

NA

None

None

None

None

None

American Heart Association†

None

Dianne Atkins

University of Iowa

None

None

None

None

None

None

None

Jason A. Bartos

University of Minnesota

None

None

None

None

None

None

None

Jose G. Cabanas

Wake County EMS

None

None

None

None

None

None

None

Dazhe Cao

University of Texas Southwestern Medical Center

Medical Toxicology Foundation*

None

None

None

None

None

None

Katie N. Dainty

North York General Hospital

AMS Healthcare*; Canadian Institutes of Health Research*

None

None

None

None

Philips Healthcare*

None

Cameron Dezfulian

Baylor College of Medicine

None

None

None

None

None

None

None

Aaron J. Donoghue

The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine

None

None

None

None

None

None

None

Ian R. Drennan

University of Toronto (Canada)

ZOLL Medical†

None

ZOLL Medical†

None

None

None

None

Jonathan Elmer

University of Pittsburgh

None

None

None

None

None

None

None

Karen G. Hirsch

Stanford University

NIH*

None

None

None

None

None

None

Ahamed H. Idris

University of Texas Southwestern Medical Center at Dallas

None

None

None

None

None

None

None

Benny L. Joyner

State University of New York, University at Buffalo

None

None

None

None

None

None

None

Beena D. Kamath-Rayne

American Academy of Pediatrics

None

None

None

None

None

None

None

Monica E. Kleinman

Boston Children's Hospital

Children's Hospital of Philadelphia*

PRG S&T†

None

None

None

None

None

Michael C. Kurz

University of Chicago

None

None

None

None

None

None

None

Javier J. Lasa

Children's Health Systems of Texas, UT Southwestern Medical Center

None

None

None

None

None

None

None

Henry C. Lee

University of California San Diego

None

None

None

None

None

None

None

Mary E. McBride

Lurie Children's Heart Center

None

None

None

None

None

American Heart Association†

None

Ashish R. Panchal

The Ohio State University Wexner Medical Center

None

None

None

None

None

None

None

Tia T. Raymond

Medical City Children's Hospital

None

None

None

None

None

None

None

Jon C. Rittenberger

Guthrie Medical Center

None

None

None

Cipriani and Werner, PC*

None

None

None

Stephen M. Schexnayder

Univ. of Arkansas/ Arkansas Children's Hospital

None

None

None

None

Love & Kirschenbaum LLLC†

American Heart Association†

Edgardo Szyld

Indiana University

None

None

None

None

None

None

None

Alexis Topjian

Children's Hospital of Philadelphia & University of Pennsylvania School of Medicine

NIH†

None

None

None

None

Elsevier†

None

Jane G. Wigginton

UT Dallas

None

None

None

None

None

None

None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $5,000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $5,000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*Modest.
†Significant.